Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
112results about How to "Many formats" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Activin-ActRIIa antagonists and uses for promoting bone growth
ActiveUS20070249022A1Increase in mineralizationReduce expressionPeptide/protein ingredientsAntibody mimetics/scaffoldsCancer researchAntagonist
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density.
Owner:ACCELERON PHARMA INC
Use of GDF traps to increase red blood cell levels
ActiveUS20100068215A1Improve pharmacokineticsImprove purification effectPeptide/protein ingredientsAntibody mimetics/scaffoldsPrimateRed Cell
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and / or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Owner:ACCELERON PHARMA INC
Activin-ActRII antagonists and uses for increasing red blood cell levels
ActiveUS20090047281A1Easy to produceReduce expressionCompound screeningApoptosis detectionPrimateRed Cell
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and / or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Owner:ACCELERON PHARMA INC
Activin-actriia antagonists and uses for decreasing or inhibiting FSH secretion
ActiveUS20090118188A1Inhibit growthAvoid survivalHormone peptidesPeptide/protein ingredientsAndrologyPlant Germ Cells
In certain aspects, the present invention provides compositions and methods for decreasing FSH levels in a patient. The patient may, for example, be diagnosed with an FSH-related disorder or desire to delay or inhibit germ cell maturation.
Owner:ACCELERON PHARMA INC
Activin-actriia antagonists and uses for treating or preventing breast cancer
ActiveUS20090074768A1Inhibit growthAvoid survivalPeptide/protein ingredientsAntibody mimetics/scaffoldsGynecologyAntagonist
In certain aspects, the present invention provides compositions and methods for treating or preventing breast cancer in humans.
Owner:ACCELERON PHARMA INC
Activin-actriia antagonists and uses for promoting bone growth in cancer patients
ActiveUS20090142333A1Promote growthStimulates of mineralizationPeptide/protein ingredientsAntibody mimetics/scaffoldsIncreased Bone DensityBone growth
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density, as well as for the treatment of multiple myeloma.
Owner:ACCELERON PHARMA INC
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
ActiveUS8216997B2Increased formationImprove the level ofOrganic active ingredientsPeptide/protein ingredientsPrimatePhysiology
Owner:ACCELERON PHARMA INC
Cardiac output measurement using dual oxygen sensors in right and left ventricles
InactiveUS7164948B2Easy to deployAvoiding excessive formationTransvascular endocardial electrodesCatheterMeasurement deviceCardiac pacemaker electrode
A pacemaker provides multi-chamber pacing with a pacing interval that can be programmed and adapted in response to cardiac output measurements for a given patient. In a typical embodiment, the pacemaker may provide pacing stimuli to both ventricles of a heart. In addition, the invention may include a measurement device that incorporates first and second blood oxygen saturation sensors for deployment in the left and right ventricle. The oxygen saturation sensors provide a differential measurement that can be used to calculate cardiac output in accordance with the Fick method. The oxygen saturation sensors may be carried by a common trans-septal lead that positions one of the sensors proximate the right ventricle and the other sensor proximate the left ventricle. Alternatively, the oxygen saturation sensors may be deployed via separate leads. Whether single or dual leads are used to carry the oxygen saturation sensors, a respective lead may optionally carry electrodes for sensing, pacing, or both.
Owner:MEDTRONIC INC
Activin-actrii antagonists and uses for increasing red blood cell levels
ActiveUS20090163417A1Reduce expressionIncrease redCompound screeningApoptosis detectionPrimateRed Cell
Owner:ACCELERON PHARMA INC
Method of increasing red blood cell levels or treating anemia in a patient
ActiveUS8058229B2Low affinityReduce impactPeptide/protein ingredientsAntibody mimetics/scaffoldsPrimateRed Cell
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and / or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Owner:ACCELERON PHARMA INC
Antagonists of activin-actriia and uses for increasing red blood cell levels
ActiveUS20100028331A1Easy to produceReduce expressionPeptide/protein ingredientsAntibody mimetics/scaffoldsPrimateRed Cell
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and / or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Owner:ACCELERON PHARMA INC
Activin-ActRIIa antagonists and uses for promoting bone growth
ActiveUS20090098113A1Reduce expressionPromote bone growthPeptide/protein ingredientsAntibody mimetics/scaffoldsIncreased Bone DensityBone growth
Owner:ACCELERON PHARMA INC
Activin-ActRIIa antagonists and uses for promoting bone growth
ActiveUS20090099086A1Reduce expressionPromote bone growthPeptide/protein ingredientsAntibody mimetics/scaffoldsIncreased Bone DensityCancer research
Owner:ACCELERON PHARMA INC
Antagonists of actriib and uses for increasing red blood cell levels
InactiveUS20100028332A1Distribution moreMany formatsPeptide/protein ingredientsAntibody mimetics/scaffoldsRed CellAntagonist
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and / or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Owner:ACCELERON PHARMA INC
Use of gdf traps to increase red blood cell levels
ActiveUS20120015877A1Distribution moreMany formatsPeptide/protein ingredientsAntibody mimetics/scaffoldsPrimateRed Cell
Owner:ACCELERON PHARMA INC
Methods for dosing an activin-actriia antagonist and monitoring of treated patients
InactiveUS20100015144A1Undesired effectImprove the level ofPeptide/protein ingredientsAntibody mimetics/scaffoldsHematologyAntagonist
In certain aspects, the present invention provides methods for dosing a patient with an activin-ActRIIa antagonist and methods for managing patients treated with an activin-ActRIIa anatagonist. In certain aspects, the methods involve measuring one or more hematologic parameters in a patient.
Owner:ACCELERON PHARMA INC
Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
ActiveUS20110038831A1Increase formationHigh levelOrganic active ingredientsPeptide/protein ingredientsCellular levelRodent
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and / or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Owner:ACCELERON PHARMA INC
Actriib antagonists and dosing and uses thereof
InactiveUS20110070233A1Improve bone strengthIncrease bone densityOrganic active ingredientsPeptide/protein ingredientsIncreased Bone DensityBone growth
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density, as well as for the treatment of multiple myeloma. Methods for dosing a patient with an ActRIIb antagonist are also provided.
Owner:ACCELERON PHARMA INC
Methods for dosing an actriib antagonist and monitoring of treated patients
InactiveUS20100008918A1Increase red blood cellRaise hemoglobin levelsPeptide/protein ingredientsAntibody mimetics/scaffoldsAntagonistTreated patient
In certain aspects, the present invention provides methods for dosing a patient with an ActRIIb antagonist and methods for managing patients treated with an ActRIIb anatagonist. In certain aspects, the methods involve measuring one or more hematologic parameters in a patient.
Owner:ACCELERON PHARMA INC
Antagonists of activin-actriia and uses for increasing red blood cell levels
ActiveUS8895016B2Reduce expressionIncrease red blood cell and hemoglobin levelPeptide/protein ingredientsAntibody mimetics/scaffoldsPrimateRed blood cell
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and / or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Owner:ACCELERON PHARMA INC
Antagonists of actriib and uses for increasing red blood cell levels
InactiveUS20120003218A1Distribution moreMany formatsHormone peptidesPeptide/protein ingredientsPrimateRed Cell
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and / or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Owner:ACCELERON PHARMA INC
Method of promoting bone growth by an anti-activin B antibody
ActiveUS8128933B2Reduce expressionPromote bone growthHormone peptidesPeptide/protein ingredientsIncreased Bone DensityBone growth
Owner:ACCELERON PHARMA INC
Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion
ActiveUS7960343B2Distribution moreMany formatsHormone peptidesPeptide/protein ingredientsGerm cellAntagonist
Owner:ACCELERON PHARMA INC
Activin-ActRIIa antagonists and uses for treating multiple myeloma
ActiveUS8173601B2Reduce expressionPromote bone growthPeptide/protein ingredientsAntibody mimetics/scaffoldsIncreased Bone DensityBone growth
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density, as well as for the treatment of multiple myeloma.
Owner:ACCELERON PHARMA INC
Activin-actriia antagonists and uses for treating multiple myeloma
ActiveUS20130004489A1Reduce expressionPromote bone growthPeptide/protein ingredientsAntibody mimetics/scaffoldsIncreased Bone DensityBone growth
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density, as well as for the treatment of multiple myeloma.
Owner:ACCELERON PHARMA INC
Frequency compounding ultrasound pulses for imaging and therapy
InactiveUS20150258352A1Minimizing thermal effectLesions be quite smallUltrasound therapySurgerySonificationCavitation
Methods and devices for producing cavitation in tissue are provided. In one embodiment, a low-frequency ultrasound pulse is transmitted into tissue, a high-frequency ultrasound pulse is transmitted into tissue, and a composite waveform is formed in the tissue that has a peak negative pressure value that exceeds an intrinsic threshold for cavitation in the tissue. In some embodiments, the peak negative pressures of the individual ultrasound pulses do not exceed the intrinsic threshold for cavitation. In another embodiment, a plurality of ultrasound pulses at various resonant frequencies are transmitted into tissue, and the time delays between these transmissions are adjusted to allow the ultrasound pulses to align temporally and form a monopolar pulse having a compound peak negative pressure that exceeds an intrinsic threshold for cavitation in the tissue. Systems for performing Histotripsy therapy are also discussed.
Owner:RGT UNIV OF MICHIGAN
Activin-actriia antagonists and uses for treating or preventing breast cancer
ActiveUS9526759B2Improve targetingDistribution moreImpression capsPeptide/protein ingredientsGynecologyAntagonist
Owner:ACCELERON PHARMA INC
Serum amyloid p derivatives and their preparation and use
One aspect of the present invention relates to the surprising discovery that modification of a glycan structure on a human SAP polypeptide can increase the biological activity of the SAP polypeptide relative to a corresponding sample of wild-type SAP isolated from human serum. The disclosure provides both variant human SAP polypeptides and methods for making the same. In particular, the present invention provides methods and compositions for in vitro and in vivo addition, deletion, or modification of sugar residues to produce SAP polypeptides, such as a human SAP polypeptide, having a desired glycosylation pattern.
Owner:PROMEDIOR
Flux system to reduce copper cracking
InactiveUS20070051702A1Reduction of copper crackingReduces copper crackingArc welding apparatusWelding/cutting media/materialsCopperMolten slag
Owner:LINCOLN GLOBAL INC
Integrated system and method for social opinion networking
InactiveUS20140100924A1Facilitates social-networkingAvoid being less adaptableVoting apparatusError detection/correctionHardware architectureDemographic data
A computer solution inclusive of web-enabled client-server hardware architecture and a unique software method for soliciting, sharing and influencing opinions on social issues. The software gathers metrics from collective opinions and facilitates social-networking using these metrics to guide members in forming informed opinions. Specifically, users are given feedback on their personal opinion selections, others' opinion selections, % in agreement, and other statistics or demographics. Each user is given the ability to “Change Opinion” base on this feedback.
Owner:INGENITO ROBERT +1
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com